RI89 Pill - yellow oval, 12mm
Pill with imprint RI89 is Yellow, Oval and has been identified as Minocycline Hydrochloride 50 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Minocycline is used in the treatment of Acne; Bacterial Infection; Bartonellosis; Actinomycosis; Bullous Pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RI89
Minocycline Hydrochloride
- Imprint
- RI89
- Strength
- 50 mg
- Color
- Yellow
- Size
- 12.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- Inactive Ingredients
-
crospovidone,
ferric oxide yellow,
lactose monohydrate,
polyethylene glycol 6000,
microcrystalline cellulose,
stearic acid,
titanium dioxide,
silicon dioxide,
magnesium stearate,
hypromelloses
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 63304-0697 | Ranbaxy Pharmaceuticals Inc. |
| 13668-0485 | Torrent Pharmaceuticals Limited |
Related images for "RI89"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (562)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline (Oral) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Dynacin, Solodyn, Minolira, ... +2 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Solodyn, Minocin for Injection, Minolira, Ximino
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
